Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading update

9 Nov 2015 15:57

RNS Number : 0909F
Imaginatik PLC
09 November 2015
Β 

9 November 2015

Imaginatik Plc

Β 

("Imaginatik" or "the Company")

Β 

Trading Update

Β 

Β 

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of consultancy and technology products, provides a trading update covering the first half of the Company's financial year to 30 September 2015.

Β 

The Company expects to report an increase in recognised revenues of approximately 33% to Β£1.96m (2014: Β£1.47m). This increase combined with the containment of costs will reduce the half year losses to approximately Β£0.41m (2014: Β£0.70m). Particularly encouraging is the increase of approximately 91% in overall bookings in the period to Β£1.97m (2014: Β£1.03m at constant currency). This has been driven primarily by the successful completion of several large multi-year renewals with existing clients. We are pleased to report that we renewed 14 out of the 17 contracts available for renewal and secured 87% of the available renewal revenues in the period.

Β 

In addition, we closed contracts in the period with several new clients including Eli Lilly, Landauer and Alaska Air.

Β 

We are also pleased to report continued progress in the Consulting division, including successfully growing our footprint with several existing customers and expanding the range of our consultancy engagements to include portfolio valuation work, the creation of long term strategy for creating deep innovation capabilities as well as our more traditional consulting support work with our Innovation Central technology platform.

Β 

As we enter the second half of the year, we are currently in contract discussions with a number of other companies and expect to complete several new contracts in the next few weeks. We expect the momentum in the Consulting division to continue, with several new consulting opportunities being developed. There is an equally large number of clients available to renew with us in the second half of the year and we are working diligently to achieve a similar or better result than that achieved in the first half year.

Β 

As stated in previous announcements, as a small company with relatively few high value contracts, the management of cash resources can at times be a challenge. During the period the Company's Chairman, Matt Cooper, advanced the Company $110,000 as a short term loan, of which $50,000 has now been repaid. The balance of this loan together with the balance of the $250,000 loan advanced in January 2015 is scheduled to be repaid over the coming months. The Company will continue to carefully manage its cash reserves and will be considering its various funding options to ensure that the business maintains sufficient levels of investment during this growth phase.

Β 

Matt Cooper, Non-Executive Chairman, commented: "The Board is pleased with the progress Imaginatik is making. The quality of the client base is outstanding for a company of our size and we are seeing pleasing growth in new innovation consulting opportunities."

Β 

Β 

The Company expects to report interim results for the six month period to 30 September 2015 in early December.

Β 

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 01329 243 243

Matt Cooper Non-Executive Chairman

Ralph Welborn, CEO

Shawn Taylor, CFO

finnCap Ltd

Tel: 020 7220 0500

Jonny Franklin-Adams/Giles Rolls

Daniel Stewart & Company

Tel: 020 7776 6550

Martin Lampshire/David Coffman

Alma PR

Tel: 020 7796 9085

Hilary Buchanan

Β 

About Imaginatik

Β 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, The Chubb Group of Insurance Companies, Exxon Mobil, Altria, Shell, Mayo Clinic, Goodyear, the Yorkshire Building Society, Pitney Bowes and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

Β 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Fareham, UK. For more information visitΒ www.imaginatik.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUGGWAGUPAGAB
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.